Xspray Pharma: Vital step forward

Research Note

2019-12-19

10:39

Xspray has taken a significant step forward after successfully manufactured the first batch of HyNap-Dasa tablets. Also, approval to start the pivotal studies has been obtained from the Ethical Committee in Canada.

JS

Jakob Svensson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.